Correspondence | Published:

Reply to “STOX1 is not imprinted and is not likely to be involved in preeclampsia”

Nature Genetics volume 39, pages 280281 (2007) | Download Citation

Subjects

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Nat. Genet. 39, 279–280 (2007).

  2. 2.

    et al. Nat. Genet. 37, 514–519 (2005).

  3. 3.

    et al. Hum. Genet. 120, 607–612 (2007).

  4. 4.

    et al. Mol. Hum. Reprod. 10, 589–598 (2004).

  5. 5.

    et al. Gene Expr. Patterns 4, 61–65 (2004).

  6. 6.

    et al. Hum. Mol. Genet. 12, 2993–3005 (2003).

  7. 7.

    et al. Nat. Med. 13, 218–223 (2007).

Download references

Author information

Affiliations

  1. Department of Clinical Chemistry, Vrije University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

    • Marie van Dijk
    • , Jan van Bezu
    • , Marinus A Blankenstein
    •  & Cees B M Oudejans
  2. Department Obstetrics and Gynecology, The Chinese University of Hong Kong, Shatin, Hong Kong, China.

    • Stephen S Chim
  3. Department of Chemical Pathology, The Chinese University of Hong Kong, Shatin, Hong Kong, China. CBM.Oudejans@vumc.nl

    • Y M Dennis Lo

Authors

  1. Search for Marie van Dijk in:

  2. Search for Jan van Bezu in:

  3. Search for Stephen S Chim in:

  4. Search for Y M Dennis Lo in:

  5. Search for Marinus A Blankenstein in:

  6. Search for Cees B M Oudejans in:

Competing interests

Y.M.D.L. and S.S.C. have filed patent applications on epigenetic markers for prenatal monitoring. The VU Medical Center has filed a patent application related to a method for diagnosing preeclampsia.

Supplementary information

PDF files

  1. 1.

    Supplementary Fig. 1

    The STOX1 CpG island is unmethylated.

  2. 2.

    Supplementary Methods

About this article

Publication history

Published

DOI

https://doi.org/10.1038/ng0307-280

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing